比较疟疾的快速诊断检验
|
By LabMedica International staff writers Posted on 28 Jun 2018 |
|
图片：Deki读片仪是一台结实的体外诊断设备，与通称为快速诊断检验的市售侧流免疫测定配套使用（图片蒙Fio公司惠赐）。
疟疾病例的诊疗包括早期的诊断和及时的有效治疗，它仍是疟疾控消战略的一个要素。虽然显微镜检是标准的疟疾诊断工具及金标准，但却不被频繁使用，因为资源贫乏地区的化验场地没有配备显微镜，还缺少技术娴熟的读片员。
现在提倡医疗机构使用快速诊断检验(RDT)来替代或者辅助显微镜检，因为医疗工作者只需接受较少培训、使用较少设备就能轻松使用，还可由非专业人员在远程操控。RDT能快速给出结果，便于患者的初次治疗和后续治疗。
一组来自多国的科学家与坦桑尼亚莫希市的乞力马扎罗基督教医科大学学院(http://kcmuco.ac.tz)合作，从1,423名过去24小时内报告发烧和/或其它疟疾症状、腋下体温≥ 37.5 °C的门诊病人中招募了1,293人。参与研究者的年龄中值为21岁，大多数参与者(71.4%; 923/1293)年龄从18岁到24岁。三分之二强(69.1%; 893/1293)是男性。
这项研究使用了韩国龙仁市标准诊断股份有限公司(www.alere.com)的SD Bioline疟疾抗原Pf/pan RDT诊断疟疾，它可检测PfHRP2（恶性疟原虫）与pLDH (pan)，同时还做了显微镜检。由经验丰富的高级显微镜检师检查染过色的涂片。加拿大安大略省多伦多市Fio公司的Deki读片仪(DR, http://fio.com)能提供自动化序列程序，引导操作人员执行RDT检验。该设备捕获一帧图像并识别出RDT的记号后，提示用户从设备中拿出RDT，再从患者身上抽血。
Deki读片仪解读疟疾快速诊断检验结果的灵敏度为94.1%，而目测的灵敏度为93.9%。疟疾快速诊断检验结果的特异性为71.8%，而人眼解读的特异性为72.0%。Deki读片仪和目测解读疟疾RDT结果的阳性预测值分别为75.8和75.4%，而阴性预测值分别为92.8和92.4%。DR和目测解读RDT的准确率分别为82.6和82.1%。
该研究的论文发表于2018年5月29日的《疟疾杂志》(Malaria Journal)。作者总结说，自动化DR与无经验医疗工作者的目测解读RDT的效果没有显著差异。然而，虽然该设备性能参数相近，但确实有用，因为它能一步一步引导用户处理RDT、数据传输以及上报。
标准诊断股份有限公司>>> www.alere.com
Fio公司 >>> http://fio.comLinks:
Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Clinical Chemistry System
P780
 (3) (1).png){kind=logo}
Pipette
Accumax Smart Series
Latest 免疫学 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read more
Molecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channel
Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read more
Microbiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more
AI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read more
Pathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read more
Technology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read more
Aptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channel
New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more